广西扶绥县肝癌家系人群TSPAN8基因单核苷酸多态性与肝癌遗传易感性研究
[Abstract]:Objective: To investigate the relationship between the single nucleotide polymorphism of TSPAN8 gene rs1051334 and rs2270587 loci and the genetic susceptibility to HCC families in the high incidence area of liver cancer in Fusui County, Guangxi. Methods: a case control study was used to collect 20 HCC families (79 cases, including 20 cases of liver cancer and 59 cases of direct relatives) in the high incidence area of liver cancer in Fusui County, Guangxi. 10 normal controls (a total of 40 cases) were used as the research object, using time of flight mass spectrometry (MALDI-TOF) to detect TSPAN8 gene rs1051334 and rs2270587 genotype. The data were statistically analyzed using SPSS 17 software. All statistical analysis results were tested by bilateral probability, and P0.05 was statistically significant. According to H Ardy-Weinberg's law of genetic balance was used to detect the genotypic degree of genotype in each group. The difference of genotype distribution in each group was calculated using the chi square ~2 test. The relationship between the genotype polymorphism of the candidate loci and the genetic susceptibility of HCC families was analyzed by the non conditional Logistic regression model. Results: 1. (1) TSPAN8 of the HCC family group The gene rs1051334 loci carried TT, TG, and GG3 genotypes, and their distribution frequencies were 55.7%, 34.2%, 10.1% respectively. The rs1051334 loci of TSPAN8 gene in the control family group were carried by TT, TG, and GG3 genotypes, and the distribution frequencies were 62.2%, 35.1%, and 2.7%. two respectively. (2) the hepatocellular carcinoma HCC group group TS The rs2270587 loci of the PAN8 gene carry CC, CT, and TT3 genotypes, the frequencies of which are 67.1%, 31.6%, 1.3% respectively. The TSPAN8 gene rs2270587 loci of the control family group carry CC, CT, TT3 genotypes, and the frequencies of the genotype are 50%, 45%, and 5.0%. two, respectively. The frequency of T allele of TSPAN8 gene rs1051334 loci of HCC non patient group and normal control family group was 72.5%, 72.9% and 79.7% respectively, and the frequency of G allele was 27.5% and 27.1% respectively. There was no significant difference in the allele frequency distribution of 20.3%. HCC group and non patient group (x ~2=0.002, P=0.963), HCC high hair family. There was no significant difference in the allele frequency distribution between the group and the normal control group (x ~2=0.771, P=0.380). In the non patient group of the HCC family, the risk of HCC carrying GT genotype was 1.15 times that of the TT genotype (95%CI 0.32~4.13), and the risk of HCC carrying GG genotype was TT based. 0.62 times (95%CI 0.08~4.87) of the type individual. In the normal control group, the risk of HCC in individuals carrying GT genotype was 2.82 times as high as that of the TT genotype (95%CI 0.52~15.27), and the risk of HCC carrying GG genotype was 3.61 times that of the TT genotype (95%CI 0.21~63.44), but the difference was not statistically significant. (2) (2) the frequency of the C allele of the rs2270587 locus of the TSPAN8 gene was 90%, 80.5% and 72.5% in the non patient group and the normal control group, respectively, and the frequency of the T allele was 10% and 19.5%, respectively, and there was no significant difference in the allele frequency distribution between the HCC patients and the non patients group (x ~2=1). .899, P=0.168), the allele frequency distribution of HCC patients was significantly different from that of normal control family group (x ~2=4.812, P=0.028). The risk of HCC in individuals carrying T allele in normal control family group was 0.29 times as much as C allelic individuals (95%CI 0.09~0.92). The risk of HCC with the CT genotype was 0.42 times that of the CC genotype (95%CI 0.11~1.66), but there was no significant difference (P0.05). The risk of cancer carrying the TT genotype could not be calculated. In the normal control family group, the risk of carrying HCC in CT based individuals was carried by the CC genotype individual. 0.34 times (95%CI 0.07~1.59), but no significant difference (P0.05), the risk of hepatocellular carcinoma with TT genotype could not be calculated. Conclusion: 1. in the population of the TSPAN8 gene in Fusui County, Guangxi, the genotype distribution of the rs2270587 loci conforms to the Hardy-Weinberg genetic balance law, and the 2.TSPAN8 gene rs1051334 loci single nucleotide. There is no significant correlation between polymorphism and genetic susceptibility to liver cancer families in Fusui County, Guangxi. The single nucleotide polymorphism of 3.TSPAN8 gene rs2270587 loci is related to the genetic susceptibility of liver cancer families in Fusui County of Guangxi, and the rs2270587 locus T allele is the protection factor of HCC in Fusui County of Guangxi.
【学位授予单位】:广西医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R735.7
【参考文献】
相关期刊论文 前10条
1 武金才;周开伦;陈家诚;陈良;唐荣;陈骋;许达峰;郑进方;张震生;李灼日;;Tspan8过表达与肝癌上皮间变及转移的关系[J];中华肝胆外科杂志;2016年11期
2 王春玲;陈良;周开伦;张震生;唐荣;陈平平;许达峰;陈骋;李灼日;武金才;;Tspan8过表达与肝癌转移潜能及预后的关系[J];中国普通外科杂志;2016年07期
3 Sarah Heiler;Zhe Wang;Margot Z?ller;;Pancreatic cancer stem cell markers and exosomes- the incentive push[J];World Journal of Gastroenterology;2016年26期
4 黎沙;岳惠芬;崔英;梁新强;刘海洲;罗兰英;杨亮;;广西扶绥县原发性肝癌家系的调查分析[J];中国癌症防治杂志;2015年03期
5 魏矿荣;彭侠彪;梁智恒;岑惠珊;;全球肝癌流行概况[J];中国肿瘤;2015年08期
6 方婷婷;刘彬彬;;四次跨膜超家族蛋白3在肿瘤中的研究进展[J];医学综述;2015年05期
7 任宇鹏;宋纯;孟庆凯;;Tspan8在结肠癌细胞中的表达及小干扰RNA干扰后对SW620细胞功能的影响[J];中国医科大学学报;2015年01期
8 吴慕云;王希成;;应用下一代测序技术检测肿瘤单核苷酸多态性研究进展[J];广东药学院学报;2014年04期
9 杨春晓;张玉;师少军;;SNP基因分型检测技术及应用进展[J];中国药师;2013年06期
10 王捷;陈汝福;唐启彬;;原发性肝癌多学科治疗模式[J];肝胆外科杂志;2013年01期
,本文编号:2173066
本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2173066.html